326 related articles for article (PubMed ID: 37337630)
1. The crisscross between p53 and metabolism in cancer.
Mao Y; Jiang P
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):914-922. PubMed ID: 37337630
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor p53 and its mutants in cancer metabolism.
Liu J; Zhang C; Hu W; Feng Z
Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
[TBL] [Abstract][Full Text] [Related]
3. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.
Lacroix M; Riscal R; Arena G; Linares LK; Le Cam L
Mol Metab; 2020 Mar; 33():2-22. PubMed ID: 31685430
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor p53 and its gain-of-function mutants in cancer.
Liu J; Zhang C; Feng Z
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor suppressor p53 in metabolism and energy regulation, and its implication in cancer and lifestyle-related diseases.
Hashimoto N; Nagano H; Tanaka T
Endocr J; 2019 Jun; 66(6):485-496. PubMed ID: 31105124
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.
Yue X; Zhao Y; Xu Y; Zheng M; Feng Z; Hu W
J Mol Biol; 2017 Jun; 429(11):1595-1606. PubMed ID: 28390900
[TBL] [Abstract][Full Text] [Related]
7. p53 regulates lipid metabolism in cancer.
Chen LL; Wang WJ
Int J Biol Macromol; 2021 Dec; 192():45-54. PubMed ID: 34619274
[TBL] [Abstract][Full Text] [Related]
8. p53 as a Regulator of Lipid Metabolism in Cancer.
Parrales A; Iwakuma T
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973397
[TBL] [Abstract][Full Text] [Related]
9. Awakening the "guardian of genome": reactivation of mutant p53.
Binayke A; Mishra S; Suman P; Das S; Chander H
Cancer Chemother Pharmacol; 2019 Jan; 83(1):1-15. PubMed ID: 30324219
[TBL] [Abstract][Full Text] [Related]
10. [Advances on mutant p53 research].
Li DH; Zhang LQ; He FC
Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor p53 and metabolism.
Liu J; Zhang C; Hu W; Feng Z
J Mol Cell Biol; 2019 Apr; 11(4):284-292. PubMed ID: 30500901
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
Blandino G; Di Agostino S
J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic roles of mutant p53 governing lipid metabolism.
Loughran RM; Emerling BM
Adv Biol Regul; 2022 Jan; 83():100839. PubMed ID: 34840111
[TBL] [Abstract][Full Text] [Related]
14. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.
Maddocks OD; Berkers CR; Mason SM; Zheng L; Blyth K; Gottlieb E; Vousden KH
Nature; 2013 Jan; 493(7433):542-6. PubMed ID: 23242140
[TBL] [Abstract][Full Text] [Related]
15. Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism.
Eriksson M; Ambroise G; Ouchida AT; Lima Queiroz A; Smith D; Gimenez-Cassina A; Iwanicki MP; Muller PA; Norberg E; Vakifahmetoglu-Norberg H
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993478
[No Abstract] [Full Text] [Related]
16. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
[TBL] [Abstract][Full Text] [Related]
17. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
18. An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.
Huang Y; Jiao Z; Fu Y; Hou Y; Sun J; Hu F; Yu S; Gong K; Liu Y; Zhao G
Eur J Med Chem; 2024 Feb; 265():116121. PubMed ID: 38194777
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Ferraiuolo M; Verduci L; Blandino G; Strano S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
[TBL] [Abstract][Full Text] [Related]
20. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
Stiewe T; Haran TE
Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]